SUPPORT AGREEMENTSupport Agreement • May 15th, 2023 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • Delaware
Contract Type FiledMay 15th, 2023 Company Industry JurisdictionTHIS SUPPORT AGREEMENT (this “Support Agreement”) is made and entered into as of February 24, 2023, by and between (i) each of the undersigned identified on the signature page hereof as a “Securityholder” (each, a “Securityholder”); (ii) DMK Pharmaceuticals Corporation, a New Jersey corporation (“DMK”); (iii) Adamis Pharmaceuticals Corporation, a Delaware corporation (“APC”); and (iv) Aardvark Merger Sub, Inc., a Delaware corporation (“Merger Sub,” and together with APC, “Adamis”).
SUPPORT AGREEMENTSupport Agreement • February 27th, 2023 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 27th, 2023 Company Industry JurisdictionTHIS SUPPORT AGREEMENT (this “Support Agreement”) is made and entered into as of February 24, 2023, by and between (i) each of the undersigned identified on the signature page hereof as a “Securityholder” (each, a “Securityholder”); (ii) DMK Pharmaceuticals Corporation, a New Jersey corporation (“DMK”); (iii) Adamis Pharmaceuticals Corporation, a Delaware corporation (“APC”); and (iv) Aardvark Merger Sub, Inc., a Delaware corporation (“Merger Sub,” and together with APC, “Adamis”).
SUPPORT AGREEMENTSupport Agreement • February 27th, 2023 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 27th, 2023 Company Industry JurisdictionTHIS SUPPORT AGREEMENT (this “Support Agreement”) is made and entered into as of February 24, 2023, by and between (i) each of the undersigned identified on the signature page hereof as a “Securityholder” (each, a “Securityholder”); (ii) DMK Pharmaceuticals Corporation, a New Jersey corporation (“DMK”); (iii) Adamis Pharmaceuticals Corporation, a Delaware corporation (“APC”); and (iv) Aardvark Merger Sub, Inc., a Delaware corporation (“Merger Sub,” and together with APC, “Adamis”).